Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Walsh is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $12.98 | 77.2% | → $23 | Initiates | → Buy | Get Alert |
| 05/16/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | $15 → $22 | Maintains | Buy | Get Alert |
| 05/10/2024 | TLSI | Buy Now | TriSalus Life Sciences | $5.57 | 187.25% | → $16 | Initiates | → Buy | Get Alert |
| 04/18/2024 | LNTH | Buy Now | Lantheus Holdings | $124.43 | -20.44% | $95 → $99 | Maintains | Buy | Get Alert |
| 04/17/2024 | ACHV | Buy Now | Achieve Life Sciences | $4.95 | 304.04% | → $20 | Initiates | → Buy | Get Alert |
| 03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 01/10/2024 | LNTH | Buy Now | Lantheus Holdings | $124.43 | -23.65% | $113 → $95 | Maintains | Buy | Get Alert |
| 11/15/2023 | CATX | Buy Now | Perspective Therapeutics | — | — | → $14 | Initiates | → Buy | Get Alert |
| 10/04/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 10/03/2023 | LNTH | Buy Now | Lantheus Holdings | $124.43 | -9.18% | → $113 | Reiterates | Buy → Buy | Get Alert |
| 09/07/2023 | CTSO | Buy Now | CytoSorbents | $1.10 | 263.67% | → $4 | Reinstates | Buy → Buy | Get Alert |
| 09/06/2023 | PRME | Buy Now | Prime Medicine | $5.73 | 249.04% | → $20 | Initiates | → Buy | Get Alert |
| 07/17/2023 | THTX | Buy Now | Theratechnologies | $1.40 | 114.29% | $24 → $12 | Maintains | Buy | Get Alert |
| 05/16/2023 | VOR | Buy Now | Vor Biopharma | $0.97 | 1754.33% | → $18 | Initiates | → Buy | Get Alert |
| 05/11/2023 | VRAY | Buy Now | ViewRay | — | — | $4 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2023 | TFFP | Buy Now | TFF Pharmaceuticals | $1.86 | 276.34% | → $175 | Initiates | → Buy | Get Alert |
| 02/10/2023 | MYNZ | Buy Now | Mainz Biomed | $0.41 | 2582.27% | → $11 | Initiates | → Buy | Get Alert |
| 10/07/2022 | PSTV | Buy Now | Plus Therapeutics | $1.88 | 165.94% | → $75 | Initiates | → Buy | Get Alert |
| 10/07/2022 | LNTH | Buy Now | Lantheus Holdings | $124.43 | -16.42% | → $104 | Initiates | → Buy | Get Alert |
| 09/07/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $10 | Initiates | → Buy | Get Alert |
| 09/07/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | → $22 | Initiates | → Buy | Get Alert |
| 05/20/2022 | HROW | Buy Now | Harrow Health | $24.85 | -19.52% | $17 → $20 | Maintains | Buy | Get Alert |
| 05/09/2022 | LNTH | Buy Now | Lantheus Holdings | $124.43 | -26.86% | → $91 | Initiates | → Buy | Get Alert |
| 05/04/2022 | CTSO | Buy Now | CytoSorbents | $1.10 | 445.5% | $7 → $6 | Maintains | Buy | Get Alert |
| 04/05/2022 | CRIS | Buy Now | Curis | $7.27 | 37.55% | $440 → $200 | Maintains | Buy | Get Alert |
| 01/19/2022 | CMPX | Buy Now | Compass Therapeutics | $1.01 | 890.1% | → $10 | Initiates | → Buy | Get Alert |
| 01/11/2022 | VRAY | Buy Now | ViewRay | — | — | → $7 | Upgrade | Neutral → Buy | Get Alert |
